We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 204

CFPB Requests Public Comments Regarding Its Use of Civil Investigative Demands
  • Troutman Sanders LLP
  • USA
  • January 25 2018

On January 24, the Consumer Financial Protection Bureau (CFPB) published a request for public comments on its use of Civil Investigative Demands or

OIG Report Highlights Impact of Improper Drug Classification
  • Arent Fox LLP
  • USA
  • January 12 2018

In late December 2017, the Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) released the findings of a report

Court Walks Back Ruling That Would Require Laboratories to Independently Verify Medical Necessity
  • Sidley Austin LLP
  • USA
  • December 15 2017

Clinical laboratories stand in a position of tension: although laboratory tests must be medically necessary to be reimbursable by federal healthcare

Health Law Update - June 15 ,2017
  • Baker & Hostetler LLP
  • USA
  • June 15 2017

Senate Republicans continue intra-party discussions on changes to House-passed legislation replacing the Affordable Care Act (ACA), but the lack of

Strategic Perspectives: Government Rekindles Concerns about CMS' MAO Overpayments
  • Pietragallo Gordon Alfano Bosick & Raspanti LLP
  • USA
  • May 22 2017

CMS estimated improper payments to Medicare Advantage Organizations (MAOs) to be 9.5 percent or $14.1 billion based on a national audit that reviewed

Avoiding Fraud and Abuse in Health Care Lending Arrangements
  • Epstein Becker Green
  • USA
  • May 10 2017

A recent settlement demonstrates the importance of compliant structuring of lending arrangements in the health care industry. The failure to consider

Additional Details Not Sufficient To Save Complaint From Public Disclosure Bar
  • Sidley Austin LLP
  • USA
  • March 27 2017

On March 22, 2017, the District Court for the Northern District of California dismissed a False Claims Act, 31 U.S.C

Healthcare Law Update: March 2017
  • Holland & Knight LLP
  • USA
  • March 24 2017

On March 3, 2017, the U.S. Department of Health and Human Services' (HHS) Office of Inspector General (OIG) issued Advisory Opinion 17-01 (Opinion

Healthcare Fraud and Abuse Review 2016
  • Bass, Berry & Sims PLC
  • USA
  • March 15 2017

Since the amendments to the False Claims Act (FCA) in 1986, results in civil matters involving allegations of healthcare fraud and abuse have amounted

Lisa M. Prather
  • Haynes and Boone LLP